 Judith Blaine
Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Podocytes | 12 | 2025 | 80 | 5.930 |
Why?
| | Receptors, Fc | 8 | 2024 | 55 | 4.270 |
Why?
| | Histocompatibility Antigens Class I | 6 | 2023 | 202 | 2.740 |
Why?
| | Actin Cytoskeleton | 2 | 2020 | 103 | 1.180 |
Why?
| | Albumins | 4 | 2024 | 118 | 1.130 |
Why?
| | Serum Albumin | 3 | 2019 | 147 | 1.040 |
Why?
| | Immunoglobulin G | 5 | 2024 | 893 | 0.990 |
Why?
| | Phosphates | 6 | 2022 | 180 | 0.900 |
Why?
| | Kidney Tubules, Proximal | 5 | 2022 | 130 | 0.880 |
Why?
| | Kidney Diseases | 3 | 2023 | 427 | 0.860 |
Why?
| | Endocytosis | 3 | 2014 | 168 | 0.840 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIa | 4 | 2022 | 9 | 0.770 |
Why?
| | Parathyroid Hormone | 4 | 2022 | 112 | 0.740 |
Why?
| | Lysosomes | 4 | 2023 | 128 | 0.730 |
Why?
| | Membrane Proteins | 3 | 2025 | 1166 | 0.680 |
Why?
| | Sodium-Phosphate Cotransporter Proteins | 5 | 2011 | 10 | 0.670 |
Why?
| | Glomerulonephritis | 1 | 2020 | 45 | 0.640 |
Why?
| | Kidney Glomerulus | 4 | 2025 | 128 | 0.590 |
Why?
| | Kidney | 8 | 2023 | 1495 | 0.580 |
Why?
| | Proteinuria | 4 | 2024 | 102 | 0.570 |
Why?
| | MicroRNAs | 1 | 2025 | 701 | 0.560 |
Why?
| | Animals | 30 | 2025 | 38058 | 0.560 |
Why?
| | Mice | 19 | 2025 | 18339 | 0.550 |
Why?
| | Mice, Knockout | 7 | 2025 | 3121 | 0.540 |
Why?
| | Fluorescein-5-isothiocyanate | 2 | 2014 | 36 | 0.520 |
Why?
| | Potassium Channels, Voltage-Gated | 3 | 2004 | 55 | 0.510 |
Why?
| | Interleukin-6 | 2 | 2019 | 780 | 0.480 |
Why?
| | Actins | 3 | 2020 | 425 | 0.460 |
Why?
| | Cells, Cultured | 8 | 2020 | 4154 | 0.450 |
Why?
| | Albuminuria | 2 | 2013 | 190 | 0.430 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIc | 2 | 2011 | 3 | 0.420 |
Why?
| | Protein Transport | 5 | 2021 | 441 | 0.420 |
Why?
| | Caveolae | 1 | 2014 | 16 | 0.420 |
Why?
| | Magnesium | 1 | 2014 | 155 | 0.420 |
Why?
| | Proteolysis | 3 | 2025 | 173 | 0.410 |
Why?
| | Complement Factor H | 2 | 2025 | 80 | 0.390 |
Why?
| | Myosin Heavy Chains | 2 | 2011 | 185 | 0.360 |
Why?
| | Protein Interaction Mapping | 1 | 2011 | 104 | 0.320 |
Why?
| | Signal Transduction | 4 | 2021 | 5226 | 0.320 |
Why?
| | Potassium Channels | 2 | 2001 | 145 | 0.290 |
Why?
| | Calcium | 2 | 2014 | 1183 | 0.290 |
Why?
| | Mice, Inbred C57BL | 7 | 2025 | 5992 | 0.290 |
Why?
| | Diabetic Nephropathies | 1 | 2012 | 318 | 0.280 |
Why?
| | Transcytosis | 2 | 2021 | 7 | 0.270 |
Why?
| | Cell Membrane | 4 | 2009 | 706 | 0.270 |
Why?
| | Phosphorus, Dietary | 3 | 2011 | 4 | 0.240 |
Why?
| | Annexin A2 | 1 | 2025 | 13 | 0.230 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2012 | 653 | 0.230 |
Why?
| | Cathepsin D | 1 | 2025 | 19 | 0.220 |
Why?
| | Cell Line | 4 | 2021 | 2882 | 0.220 |
Why?
| | Glomerulonephritis, IGA | 1 | 2024 | 12 | 0.220 |
Why?
| | Apoptosis | 1 | 2013 | 2430 | 0.210 |
Why?
| | Complement Inactivating Agents | 1 | 2024 | 74 | 0.200 |
Why?
| | Complement Pathway, Alternative | 1 | 2024 | 122 | 0.200 |
Why?
| | Microvilli | 4 | 2011 | 75 | 0.200 |
Why?
| | Antigen-Antibody Complex | 1 | 2023 | 72 | 0.190 |
Why?
| | Humans | 21 | 2025 | 144759 | 0.190 |
Why?
| | Endosomes | 1 | 2024 | 140 | 0.190 |
Why?
| | Rats | 4 | 2024 | 5597 | 0.190 |
Why?
| | Protein Isoforms | 1 | 2024 | 402 | 0.180 |
Why?
| | Hyperphosphatemia | 1 | 2022 | 15 | 0.180 |
Why?
| | Inflammation | 1 | 2013 | 2878 | 0.170 |
Why?
| | Sodium-Hydrogen Exchangers | 2 | 2011 | 22 | 0.170 |
Why?
| | Glomerular Basement Membrane | 1 | 2020 | 8 | 0.170 |
Why?
| | Autophagy-Related Proteins | 1 | 2021 | 46 | 0.170 |
Why?
| | Opossums | 2 | 2011 | 9 | 0.160 |
Why?
| | Vascular Calcification | 1 | 2022 | 110 | 0.160 |
Why?
| | Glomerular Filtration Rate | 2 | 2014 | 760 | 0.160 |
Why?
| | Homeostasis | 3 | 2014 | 640 | 0.160 |
Why?
| | Microscopy, Fluorescence | 3 | 2011 | 416 | 0.160 |
Why?
| | Focal Adhesions | 1 | 2020 | 47 | 0.160 |
Why?
| | Disease Models, Animal | 4 | 2021 | 4557 | 0.160 |
Why?
| | Nephrectomy | 1 | 2021 | 158 | 0.150 |
Why?
| | Cardiovascular Diseases | 1 | 2012 | 2168 | 0.150 |
Why?
| | Flow Cytometry | 2 | 2020 | 1173 | 0.150 |
Why?
| | Lipocalins | 1 | 2019 | 35 | 0.150 |
Why?
| | Disease | 1 | 2020 | 98 | 0.150 |
Why?
| | Cell Line, Transformed | 1 | 2019 | 140 | 0.150 |
Why?
| | Autoimmune Diseases | 1 | 2023 | 463 | 0.150 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2004 | 905 | 0.150 |
Why?
| | Cytoskeleton | 2 | 2011 | 195 | 0.150 |
Why?
| | Allografts | 1 | 2019 | 150 | 0.150 |
Why?
| | Cell Adhesion Molecules | 1 | 2019 | 178 | 0.140 |
Why?
| | Phosphoproteins | 2 | 2011 | 344 | 0.140 |
Why?
| | Autophagy | 1 | 2021 | 286 | 0.140 |
Why?
| | Ion Channel Gating | 1 | 1998 | 92 | 0.140 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2019 | 364 | 0.140 |
Why?
| | Endothelial Cells | 2 | 2025 | 869 | 0.140 |
Why?
| | Neurons | 2 | 2004 | 1640 | 0.130 |
Why?
| | Shab Potassium Channels | 3 | 2004 | 20 | 0.130 |
Why?
| | Xenopus | 3 | 2004 | 89 | 0.130 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 2 | 2014 | 38 | 0.120 |
Why?
| | Fibroblast Growth Factors | 2 | 2022 | 188 | 0.120 |
Why?
| | Cell Polarity | 2 | 2014 | 137 | 0.120 |
Why?
| | Inflammation Mediators | 2 | 2021 | 509 | 0.110 |
Why?
| | Renal Elimination | 1 | 2014 | 5 | 0.110 |
Why?
| | Renal Reabsorption | 1 | 2014 | 4 | 0.110 |
Why?
| | Gastrointestinal Absorption | 1 | 2014 | 5 | 0.110 |
Why?
| | Losartan | 1 | 2014 | 13 | 0.110 |
Why?
| | Lisinopril | 1 | 2014 | 15 | 0.110 |
Why?
| | Denys-Drash Syndrome | 1 | 2014 | 4 | 0.110 |
Why?
| | WT1 Proteins | 1 | 2014 | 12 | 0.110 |
Why?
| | Microscopy, Confocal | 2 | 2019 | 321 | 0.110 |
Why?
| | Epithelial Cells | 1 | 2021 | 1125 | 0.100 |
Why?
| | Lysosomal-Associated Membrane Protein 1 | 1 | 2014 | 12 | 0.100 |
Why?
| | Biomarkers | 3 | 2019 | 4271 | 0.100 |
Why?
| | Protease Inhibitors | 1 | 2014 | 102 | 0.100 |
Why?
| | Ion Transport | 2 | 2011 | 63 | 0.100 |
Why?
| | Mutation | 3 | 2020 | 4089 | 0.100 |
Why?
| | Vesicular Transport Proteins | 1 | 2014 | 86 | 0.100 |
Why?
| | Metabolic Diseases | 1 | 2014 | 114 | 0.100 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2014 | 221 | 0.100 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type III | 2 | 2009 | 5 | 0.090 |
Why?
| | Fluorescence Resonance Energy Transfer | 2 | 2011 | 178 | 0.090 |
Why?
| | Rats, Sprague-Dawley | 3 | 2014 | 2527 | 0.090 |
Why?
| | Caspases | 1 | 2013 | 232 | 0.090 |
Why?
| | Acute Kidney Injury | 1 | 2019 | 865 | 0.090 |
Why?
| | Orphan Nuclear Receptors | 1 | 2011 | 14 | 0.090 |
Why?
| | Absorption | 1 | 2011 | 60 | 0.080 |
Why?
| | Biological Transport, Active | 1 | 2011 | 69 | 0.080 |
Why?
| | Green Fluorescent Proteins | 2 | 2004 | 405 | 0.080 |
Why?
| | Membrane Potentials | 2 | 2004 | 280 | 0.080 |
Why?
| | Complement Activation | 2 | 2025 | 411 | 0.080 |
Why?
| | Repressor Proteins | 1 | 2014 | 437 | 0.080 |
Why?
| | Spectrometry, Fluorescence | 1 | 2011 | 168 | 0.080 |
Why?
| | Kinetics | 1 | 2014 | 1627 | 0.080 |
Why?
| | Hormones | 1 | 2011 | 134 | 0.080 |
Why?
| | Delayed Rectifier Potassium Channels | 2 | 2001 | 9 | 0.080 |
Why?
| | Cytokines | 2 | 2021 | 2061 | 0.080 |
Why?
| | Recombinant Fusion Proteins | 2 | 2004 | 675 | 0.080 |
Why?
| | Genes, Dominant | 1 | 2009 | 101 | 0.080 |
Why?
| | Potassium Deficiency | 1 | 2009 | 1 | 0.080 |
Why?
| | NF-kappa B | 1 | 2013 | 661 | 0.070 |
Why?
| | Mice, Transgenic | 1 | 2014 | 2182 | 0.070 |
Why?
| | Creatinine | 2 | 2024 | 506 | 0.070 |
Why?
| | Dopamine | 1 | 2011 | 283 | 0.070 |
Why?
| | Intestine, Small | 1 | 2009 | 166 | 0.070 |
Why?
| | Aging | 1 | 2019 | 1966 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2011 | 459 | 0.070 |
Why?
| | RNA, Messenger | 4 | 2009 | 2832 | 0.060 |
Why?
| | Hypophosphatemia, Familial | 1 | 2006 | 4 | 0.060 |
Why?
| | Gene Expression Regulation | 2 | 2013 | 2608 | 0.060 |
Why?
| | Male | 6 | 2024 | 72315 | 0.060 |
Why?
| | Sodium-Bicarbonate Symporters | 1 | 2005 | 2 | 0.060 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2005 | 153 | 0.060 |
Why?
| | Angiotensin II | 1 | 2005 | 97 | 0.060 |
Why?
| | Gene Expression | 2 | 2001 | 1490 | 0.050 |
Why?
| | Benzoates | 1 | 2024 | 50 | 0.050 |
Why?
| | Protein Kinase C | 1 | 2005 | 252 | 0.050 |
Why?
| | Renal Replacement Therapy | 1 | 2024 | 100 | 0.050 |
Why?
| | Piperidines | 1 | 2024 | 217 | 0.050 |
Why?
| | Female | 4 | 2024 | 78271 | 0.050 |
Why?
| | Protein Structure, Tertiary | 1 | 2004 | 862 | 0.040 |
Why?
| | Administration, Oral | 1 | 2024 | 847 | 0.040 |
Why?
| | Spinal Cord | 1 | 2004 | 380 | 0.040 |
Why?
| | Kv1.1 Potassium Channel | 1 | 2001 | 8 | 0.040 |
Why?
| | Microinjections | 1 | 2001 | 92 | 0.040 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 1 | 2021 | 63 | 0.040 |
Why?
| | Indoles | 1 | 2024 | 501 | 0.040 |
Why?
| | Embryo, Nonmammalian | 1 | 2001 | 173 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2021 | 173 | 0.040 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2021 | 139 | 0.040 |
Why?
| | Patch-Clamp Techniques | 1 | 2001 | 289 | 0.040 |
Why?
| | Luminescent Proteins | 1 | 2001 | 185 | 0.040 |
Why?
| | Acute-Phase Proteins | 1 | 2019 | 67 | 0.040 |
Why?
| | Isoantibodies | 1 | 2019 | 57 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2024 | 2029 | 0.040 |
Why?
| | Lipocalin-2 | 1 | 2019 | 79 | 0.040 |
Why?
| | Complement System Proteins | 1 | 2022 | 316 | 0.040 |
Why?
| | Biological Transport | 2 | 2011 | 417 | 0.040 |
Why?
| | Models, Neurological | 1 | 2001 | 254 | 0.040 |
Why?
| | Antigen Presentation | 1 | 2019 | 205 | 0.040 |
Why?
| | Hepatocytes | 1 | 2019 | 223 | 0.040 |
Why?
| | Electrophysiology | 1 | 1998 | 218 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1998 | 381 | 0.030 |
Why?
| | Risk Factors | 1 | 2012 | 10779 | 0.030 |
Why?
| | Action Potentials | 1 | 2001 | 506 | 0.030 |
Why?
| | Up-Regulation | 1 | 2019 | 851 | 0.030 |
Why?
| | Metabolomics | 1 | 2021 | 727 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 1998 | 2155 | 0.030 |
Why?
| | Molecular Sequence Data | 1 | 1998 | 2930 | 0.030 |
Why?
| | Liver X Receptors | 1 | 2011 | 30 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2014 | 1047 | 0.020 |
Why?
| | Protein Stability | 1 | 2011 | 178 | 0.020 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIb | 1 | 2009 | 8 | 0.020 |
Why?
| | Enterocytes | 1 | 2009 | 16 | 0.020 |
Why?
| | Cytoplasmic Vesicles | 1 | 2009 | 14 | 0.020 |
Why?
| | Jejunum | 1 | 2009 | 35 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 11679 | 0.020 |
Why?
| | Hypophosphatemia | 1 | 2009 | 17 | 0.020 |
Why?
| | Ligands | 1 | 2011 | 673 | 0.020 |
Why?
| | Duodenum | 1 | 2009 | 77 | 0.020 |
Why?
| | Blotting, Western | 1 | 2009 | 1187 | 0.020 |
Why?
| | Adaptation, Physiological | 1 | 2011 | 570 | 0.020 |
Why?
| | Receptor, Angiotensin, Type 1 | 1 | 2005 | 25 | 0.010 |
Why?
| | Xenopus laevis | 1 | 2005 | 105 | 0.010 |
Why?
| | Intestinal Mucosa | 1 | 2011 | 676 | 0.010 |
Why?
| | Oocytes | 1 | 2005 | 178 | 0.010 |
Why?
| | Protein Binding | 1 | 2011 | 2273 | 0.010 |
Why?
| | Transfection | 1 | 2005 | 940 | 0.010 |
Why?
| | Middle Aged | 1 | 2024 | 35875 | 0.010 |
Why?
| | Adult | 1 | 2024 | 40449 | 0.010 |
Why?
| | Models, Biological | 1 | 2005 | 1821 | 0.010 |
Why?
|
|
Blaine's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|